![Jason Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 14 078 $ am 31.08.2026
Jason Mills is currently Director at NeuroOne Medical Technologies Corp.
since 2025 and Executive Vice President-Strategy at Penumbra, Inc. since 2020.
Former positions include Managing Director at Canaccord Adams, Inc. in 2010, Managing Director at Canaccord Genuity LLC from 2007 to 2020, Principal at Broadpoint.
Gleacher Securities, Senior Research Analyst at Thomas Weisel Partners LLC, Research Associate at Gerard Klauer Mattison & Co., Inc., Research Associate at PreferredTrade, Inc., and Analyst at Canaccord Genuity, Inc. Education includes undergraduate studies at Yale University and graduate studies at The Ohio University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.04.2026 | 8’281 ( 0.09% ) | 14 078 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PENUMBRA, INC. | Corporate Officer/Principal | 12.05.2020 |
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 18.12.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Canaccord Genuity LLC
 Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.05.2020 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 21.03.2018 |
PreferredTrade, Inc.
 PreferredTrade, Inc. Investment Banks/BrokersFinance Provides securities brokerage services through the Internet | Corporate Officer/Principal | - |
Canaccord Adams, Inc.
 Canaccord Adams, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 22.04.2010 |
Gerard Klauer Mattison & Co., Inc.
 Gerard Klauer Mattison & Co., Inc. Investment Banks/BrokersFinance Provides financial services such as investment banking, equity trading, asset management and management consulting services | Corporate Officer/Principal | 01.01.2003 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Canaccord Adams, Inc.
Canaccord Adams, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Penumbra, Inc.
 Penumbra, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops invasive diagnostic and therapeutic devices for neuroscience | Health Technology |
Broadpoint.Gleacher Securities
 Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Regional BanksFinance Operates as an investment banking firm | Finance |
Gerard Klauer Mattison & Co., Inc.
Gerard Klauer Mattison & Co., Inc. Investment Banks/BrokersFinance Provides financial services such as investment banking, equity trading, asset management and management consulting services | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PreferredTrade, Inc.
PreferredTrade, Inc. Investment Banks/BrokersFinance Provides securities brokerage services through the Internet | Finance |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Canaccord Genuity LLC
Canaccord Genuity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
